Oral anticoagulation in older patients with vascular or cardiovascular diseases. Aged over 70 years: Same risk? Same benefit?

International Angiology

Volumn 22, Issue 4, 2003, Pages 370-375

  Hirschl, M ^a   Pluschnig, U ^a   Kundi, M ^a   Katzenschlager, Reinhold ^a  

^a Hanuschkrankenhaus ^*  (Austria)

Author keywords

Adverse effects; Aged; Anticoagulants; Compliance

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG INDICATION; DRUG QUALITY; DRUG STABILITY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PATIENT COMPLIANCE; PATIENT MONITORING; PRACTICE GUIDELINE; PREDICTION; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; THROMBOEMBOLISM; VASCULAR DISEASE;

ADMINISTRATION, ORAL; AGE FACTORS; AGED; ANTICOAGULANTS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 1542285969     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Sebastian JL, Tresch DD. Use of oral anticoagulants in older patients. Drugs Aging 2001;16:409-35.
2. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henifhoff JG, White RH. The risk for and severity of bleeding complications in elderly patients treated with warfarin: The National Consortium of Anticoagulation Clinics. Ann Intern Med 1996;124:970-9.
3. Petitti DB, Strom BL, Melmon KL. Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin. J Clin Epidemiol 1989;42:759-64.
4. Launbjerg J, Egenblad H, Heaf J, Nielsen NH, Fugleholm AM, Ladefoged K. Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients. J Intern Med 1991;229: 351-5.
5. Gitter MJ, Jaeger TM, Petterson TM, Gersh BJ, Silverstein MD. Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnestota. Mayo Clin Proc 1995;70:725-33.
6. Holmgren K, Anderson G, Fagrell B, Johnsson H, Ljungberg B, Nilsson Wilhelmsson S et al. One-month versus six-month therapy with oral anticoagulants after symptomatic deep venous thrombosis: a randomised study. Acta Med Scand 1985;218:279-84.
7. Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Second report of the Sixty Plus Reinfarction Study Research Group. Lancet 1982;1:64-8.
8. Hurlen M, Erikssen J, Smith P, Arnesen H, Rollag A. Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3166 outpatients. J Intern Med 1994;236:299-304.
9. Beyth RJ, Landefeld CS. Anticoagulants in older patients: a safety perspective. Drugs Aging 1995;6:45-54.
10. Hutten BA, Lensing AWA, Kraajenhagen RA, Prins MH. Safety of treatment with oral anticoagulants in the elderly. A systematic review. Drugs Aging 1999;14:303-12.
11. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998;105: 91-9.
12. Van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy. Arch Intern Med 1993;153:1557-62.
13. Launbjerg J, Egeblad H, Heaf J, Nielsen NH, Fugleholm AM, Ladefoged K. Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatient. J Intern Med 1991;229: 351-5.
14. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of oral Anticoagulant Therapy. Lancet 1996;348: 423-8.
15. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors know at the start of outpatient therapy. Am J Med 1989;87:144-52.
16. Gallus AS, Baker RI, Chong BH, Ockelford PA, Street AM. Consensus guidelines for warfarin therapy. Recommendations from the Australian Society of Thrombosis and Haemostasis. Med J Aust 2000;172:600-5.
17. Mc Mahan DA, Smith DM, Carey MA, Zhou XH. Risk of major hemorrhage for outpatients treated with warfarin. J Gen Intern Med 1998;13:311-6.
18. Fihn SD, Mc Donell M, Martin D, Henihoff J, Vermes D, Kent D et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med 1993;118:511-20.
19. Fihn SD, Callahan CM, Marhin DC, Mc Donell MB, Henihoff JG, White RH. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med 1996;124:970-9.
20. Gurwitz JH, Goldberg RJ, Holden A, Knapic N, Ansell J. Age-related risks of long-term oral anticoagulant therapy. Arch Intern Med 1988;148:1733-6.
21. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994;120:897-902.
22. Black DM, Brand RJ, Greenlick M, Hughes G, Smith J. Compliance to treatment for hypertension in elderly patients. The SHEP Pilot Study. J Gerontol 1987;42:552-7.
23. Palareti G, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M et al. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy). Thromb Haemost 1997;78:1438-43.
24. Landefeld CS, Cook EF, Flatley M, Weisberg M, Goldman L. Identification and preliminary validation of major bleeding in hospitalized patients starting anticoagulant + therapy. Am J Med 1987;82:703-13.
25. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 2000;17:3078-83.
26. Casais P, Luceros AS, Meschengieser S, Fondevila C, Santarelli MT, Lazzari MA. Bleeding riskfactoris in chronic oral anticoagulation with acenocoumarol. Am J Hematol 2000;63:192-6.
27. Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest 2001;119S-21.
28. Van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Assessment of a bleeding risk index in two cohorts patients treated with oral anticoagulant. Thromb Haemost 1996;76:12-6.
29. White RH, Mc Burnie MA, Manolio T, Furberg CD, Gardin JM, Kittner SJ et al. Oral Anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort. Am J Med 1999;106:165-71.
30. Landefeld CS, Anderson PA. Guideline-based consultation to prevent anticoagulant-related bleeding. A randomized, controlled trial in a teaching hospital. Ann Intern Med 1992;15:829-37.
31. Gage BF, Fihn SD, White RH. Warfarin therapy for an octogenarian who has atrial fibrillation. Ann Intern Med 2001;134:465-74.